MindMaze’s Post

In the last 5 years, syphilis rates increased 78.9%, making early detection and treatment critical. Read Molly Wack's latest blog to learn how Azara DRVS empowers care teams to identify and screen at-risk patients efficiently. Read now: https://hubs.la/Q02GXlPT0 #AzaraDRVS

Take a deeper dive into the 𝗛𝗢𝗥𝗨𝗦 project as project leader 𝗛𝗮𝗻𝗻𝗮𝗵 𝗞𝗮𝗺𝗶𝗻𝘀𝗸𝗶, shares insights on the team's research. She discusses how the project aims to enhance our understanding of #CMV's impact on transplant patients and the search for patient signatures to help develop personalised treatments, ultimately improving patient quality of life. #HORUS_CMV Watch the full video: https://lnkd.in/e-jJZmdc

Transforming treatment. It's what we do at Brainomix. Stop by our #ISC25 booth next week in LA to learn more about our Brainomix 360 Stroke platform, which has been shown to expand access to life-saving treatments and improve patient outcomes. #Booth811 #TransformingTreatment #Brainomix360 #ISC #LA

🚀 Transforming Healthcare with SHERPA Health: A Closer Look at Our Impact! We're excited to share the remarkable outcomes of integrating SHERPA solutions! 💡 ✅ 22% Increase in Chart Completion: Leading to improved Quality Measures.  ✅ Early Cancer Detection: 9% increase from LDCT screenings.  ✅ Enhanced Patient Screening: Significant boosts in depression and wellness screenings.  ✅ Operational Efficiency: Reduced admin times by over 10%, streamlining patient interactions. Revenue Growth(Model based on a 20 Provider Practice): $14,901 from lung screenings $18,344 from depression screenings $17,881 from mammography screenings Discover how SHERPA Health is driving efficiency and enhancing patient care. Dive into our latest results: #HealthcareInnovation #PatientCare #HealthTech #SHERPAHealth

We’re proud to highlight that today, Matthew Matasar will deliver an oral presentation at #ASH24, sharing exciting findings from the ELM-1 study. This research explores the efficacy and safety of odronextamab monotherapy for patients with relapsed/refractory #DLBCL after CAR T-cell therapy. The study highlights encouraging outcomes in a high-risk population, demonstrating a 48% ORR and 32% CR rate, with manageable safety in this challenging post-CAR T setting. Learn more about how these insights may help shape the future of patient care: https://bit.ly/4eR8T8I

Looking forward to sharing some practical tips from my own clinical experience!

Dealing with progressive MS can be overwhelming, but emerging therapies are opening new doors. On 20 Sep at ECTRIMS Patient Community Day, let’s uncover these opportunities together. Join by registering today➡️ https://buff.ly/3YtV4s1 #ECTRIMS2024 #MS #MultipleSclerosis

How #Malaffi Transformed Patient Outcomes: Dr. Hekmieh Manad’s Inspiring Story - Malaffi #Introduction Dr. Hekmieh Manad shares her inspiring story of how #Malaffi transformed patient outcomes in her healthcare facility. #Challenges Faced Dr. Manad discusses the challenges her facility faced before implementing #Malaffi, including inefficient data sharing and lack of patient information access. #Implementation Process The implementation process of #Malaffi in Dr. Manad's facility is detailed, highlighting the training and support provided to staff. #Benefits of Malaffi Dr. Manad explains the significant benefits of #Malaffi, such as improved patient care, streamlined workflows, and enhanced data security. #Patient Outcomes The positive impact of #Malaffi on patient outcomes is discussed, including faster ai.mediformatica.com #diagnosis #bloodtest #branch #cancer #clinical #earlydetection #internalmedicine #medicine #outcomes #patientcare #patientoutcomes #shares #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3A84BuB)

🔬At Neuronity, we are exploring innovative #genetherapy approaches in our pre-clinical trials, setting the stage to revolutionize #Parkinsondisease treatment. Under the visionary leadership of our CEO, Hyun Joon Lee we're crafting game-changing strategies that promise to transform care for #Parkinson’s patients. Our goal is clear: advance groundbreaking #genetherapy to make a significant impact! 💡🧬 #ParkinsonsDisease #GeneTherapy #PreClinicalResearch #AAVgenetherapy #Lentivirusgenetherapy

🏥 Saint Luke's Health System's New Digital Atrial Fibrillation Care Program ❗ Saint Luke's Mid America Heart Institute launched a new solution on its care platform. The program supports patients living with or at risk of developing Atrial Fibrillation (AFib) and aims to improve outcomes.. The solution built with Story Health, provides Saint Luke's Health System the ability to engage patients between clinic visits. Story Health's solution encompasses all aspects of evidence-based care for Atrial Fibrillation , including continuous patient support, symptom management, stroke prevention and accelerated treatment. Story Health’s AFib solution addresses the challenges of Afib care, by integrating with clinical teams within health systems, ensuring patients remain engaged with their care regimen between clinic visits. This program utilizes a virtual, asynchronous care model, backed by a technology platform and guided by experienced health coaches. These coaches help patients overcome barriers, including social determinants of health. https://lnkd.in/gV2dGXeP #digitalhealth #healthsystems #hearthealth #healthcareinnovation #Afib #